If you need more lookups,
subscriptions start at $34 USD/month.
Svend Andersen Location
Denmark
Svend Andersen Work
2026 -now Board member @
2025 -now Life science advisor, board member, investor @ CEO - Life Science 2nd Opinion
2020 -now Independent Board Member @
2017 -2024 EVP Perrigo; President CSCI @
2016 -2017 Professional Board Member and Strategic Advisor for Private Equity in London @ The Panel
2015 -2017 Non Executive Board Member @
2015 -2016 EVP Europe+ @
2010 -2015 President EMEA and Corporate Officer @
2005 -2010 Executive Vice President - Western Europe @ Actavis
2003 -2005 Vice President, General Manager - Western Europe @
now Vice President Commercial Operations @ Ferrosan A/S acquired by Pfizer
now Sales and Marketing Director @ Kores Nordic Holding
now Sales and Marketing Manager - Global @ Farma Food acquired by Ferrosan
Svend Andersen Education
Copenhagen Business School
HA; HD(A); HD(O); IAA; Insead (Finance (Strategy & Board); Dr. Bell Leadership training)
Svend Andersen Skills
GMP
Licensing
Pharmaceutical Sales
EMEA
Pharmaceutical Industry
Lifesciences
Sales Management
Medical Devices
Sop
Pharmaceutics
Regulatory Affairs
Quality System
Change Management
Business Development
Biotechnology
Sales Effectiveness
Product Launch
Market Analysis
Strategy
Life Sciences
Sales
New Business Development
Microsoft Office
Svend Andersen Summary
Svend Andersen, based in Denmark, is currently a Vice President Commercial Operations at Ferrosan A/S acquired by Pfizer. Svend Andersen brings experience from previous roles at Bavarian Nordic, CEO - Life Science 2nd Opinion, Lundbeckfonden / Lundbeck Foundation and Perrigo Company plc. Svend Andersen holds a HA; HD(A); HD(O); IAA; Insead (Finance in Strategy & Board); Dr. Bell Leadership training @ Copenhagen Business School. With a robust skill set that includes GMP, Licensing, Pharmaceutical Sales, EMEA, Pharmaceutical Industry and more. Svend Andersen has 1 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Svend Andersen?
Find contact details for 700 million professionals.